• Je něco špatně v tomto záznamu ?

SAMHD1 agit sur les fourches de réplication bloquées pour empêcher l'induction d'interféron [SAMHD1 acts at stalled replication forks to prevent interferon induction]

F. Coquel, MJ. Silva, H. Técher, K. Zadorozhny, S. Sharma, J. Nieminuszczy, C. Mettling, E. Dardillac, A. Barthe, AL. Schmitz, A. Promonet, A. Cribier, A. Sarrazin, W. Niedzwiedz, B. Lopez, V. Costanzo, L. Krejci, A. Chabes, M. Benkirane, YL....

. 2020 ; 343 (1) : 9-21. [pub] 20200605

Jazyk francouzština Země Francie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028103

DNA replication is an extremely complex process, involving thousands of replication forks progressing along chromosomes. These forks are frequently slowed down or stopped by various obstacles, such as secondary DNA structures, chromatin-acting proteins or a lack of nucleotides. This slowing down, known as replicative stress, plays a central role in tumour development. Complex processes, which are not yet fully understood, are set up to respond to this stress. Certain nucleases, such as MRE11 and DNA2, degrade the neo-replicated DNA at the level of blocked forks, allowing the replication to restart. The interferon pathway is a defense mechanism against pathogens that detects the presence of foreign nucleic acids in the cytoplasm and activates the innate immune response. DNA fragments resulting from genomic DNA metabolism (repair, retrotransposition) can diffuse into the cytoplasm and activate this pathway. A pathological manifestation of this process is the Aicardi-Goutières syndrome, a rare disease characterized by chronic inflammation leading to neurodegenerative and developmental problems. In this encephalopathy, it has been suggested that DNA replication may generate cytosolic DNA fragments, but the mechanisms involved have not been characterized. SAMHD1 is frequently mutated in the Aicardi-Goutières syndrome as well as in some cancers, but its role in the etiology of these diseases was largely unknown. We show that cytosolic DNA accumulates in SAMHD1-deficient cells, particularly in the presence of replicative stress, activating the interferon response. SAMHD1 is important for DNA replication under normal conditions and for the processing of stopped forks, independent of its dNTPase activity. In addition, SAMHD1 stimulates the exonuclease activity of MRE11 in vitro. When SAMHD1 is absent, degradation of neosynthesized DNA is inhibited, which prevents activation of the replication checkpoint and leads to failure to restart the replication forks. Resection of the replication forks is performed by an alternative mechanism which releases DNA fragments into the cytosol, activating the interferon response. The results obtained show, for the first time, a direct link between the response to replication stress and the production of interferons. These results have important implications for our understanding of the Aicardi-Goutières syndrome and cancers related to SAMHD1. For example, we have shown that MRE11 and RECQ1 are responsible for the production of DNA fragments that trigger the inflammatory response in cells deficient for SAMHD1. We can therefore imagine that blocking the activity of these enzymes could decrease the production of DNA fragments and, ultimately, the activation of innate immunity in these cells. In addition, the interferon pathway plays an essential role in the therapeutic efficacy of irradiation and certain chemotherapeutic agents such as oxaliplatin. Modulating this response could therefore be of much wider interest in anti-tumour therapy.

SAMHD1 acts at stalled replication forks to prevent interferon induction

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028103
003      
CZ-PrNML
005      
20210114153004.0
007      
ta
008      
210105s2020 fr f 000 0|fre||
009      
AR
024    7_
$a 10.5802/crbiol.10 $2 doi
035    __
$a (PubMed)32720483
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a fre
044    __
$a fr
100    1_
$a Coquel, F $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
245    10
$a SAMHD1 agit sur les fourches de réplication bloquées pour empêcher l'induction d'interféron / $c F. Coquel, MJ. Silva, H. Técher, K. Zadorozhny, S. Sharma, J. Nieminuszczy, C. Mettling, E. Dardillac, A. Barthe, AL. Schmitz, A. Promonet, A. Cribier, A. Sarrazin, W. Niedzwiedz, B. Lopez, V. Costanzo, L. Krejci, A. Chabes, M. Benkirane, YL. Lin, P. Pasero,
246    31
$a [SAMHD1 acts at stalled replication forks to prevent interferon induction].
520    9_
$a DNA replication is an extremely complex process, involving thousands of replication forks progressing along chromosomes. These forks are frequently slowed down or stopped by various obstacles, such as secondary DNA structures, chromatin-acting proteins or a lack of nucleotides. This slowing down, known as replicative stress, plays a central role in tumour development. Complex processes, which are not yet fully understood, are set up to respond to this stress. Certain nucleases, such as MRE11 and DNA2, degrade the neo-replicated DNA at the level of blocked forks, allowing the replication to restart. The interferon pathway is a defense mechanism against pathogens that detects the presence of foreign nucleic acids in the cytoplasm and activates the innate immune response. DNA fragments resulting from genomic DNA metabolism (repair, retrotransposition) can diffuse into the cytoplasm and activate this pathway. A pathological manifestation of this process is the Aicardi-Goutières syndrome, a rare disease characterized by chronic inflammation leading to neurodegenerative and developmental problems. In this encephalopathy, it has been suggested that DNA replication may generate cytosolic DNA fragments, but the mechanisms involved have not been characterized. SAMHD1 is frequently mutated in the Aicardi-Goutières syndrome as well as in some cancers, but its role in the etiology of these diseases was largely unknown. We show that cytosolic DNA accumulates in SAMHD1-deficient cells, particularly in the presence of replicative stress, activating the interferon response. SAMHD1 is important for DNA replication under normal conditions and for the processing of stopped forks, independent of its dNTPase activity. In addition, SAMHD1 stimulates the exonuclease activity of MRE11 in vitro. When SAMHD1 is absent, degradation of neosynthesized DNA is inhibited, which prevents activation of the replication checkpoint and leads to failure to restart the replication forks. Resection of the replication forks is performed by an alternative mechanism which releases DNA fragments into the cytosol, activating the interferon response. The results obtained show, for the first time, a direct link between the response to replication stress and the production of interferons. These results have important implications for our understanding of the Aicardi-Goutières syndrome and cancers related to SAMHD1. For example, we have shown that MRE11 and RECQ1 are responsible for the production of DNA fragments that trigger the inflammatory response in cells deficient for SAMHD1. We can therefore imagine that blocking the activity of these enzymes could decrease the production of DNA fragments and, ultimately, the activation of innate immunity in these cells. In addition, the interferon pathway plays an essential role in the therapeutic efficacy of irradiation and certain chemotherapeutic agents such as oxaliplatin. Modulating this response could therefore be of much wider interest in anti-tumour therapy.
650    _2
$a autoimunitní nemoci nervového systému $x patofyziologie $7 D020274
650    _2
$a DNA $7 D004247
650    _2
$a replikace DNA $7 D004261
650    _2
$a lidé $7 D006801
650    _2
$a interferony $x metabolismus $7 D007372
650    _2
$a malformace nervového systému $x patofyziologie $7 D009421
650    _2
$a helikasy RecQ $x metabolismus $7 D053484
650    _2
$a protein SAMHD1 $x metabolismus $7 D000076106
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Silva, M J $u Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia.
700    1_
$a Técher, H $u IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
700    1_
$a Zadorozhny, K $u Department of Biology and National Centre for Biomolecular Research, Masaryk University, Brno, Czech Republic.
700    1_
$a Sharma, S $u Department of Medical Biochemistry and Biophysics and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden.
700    1_
$a Nieminuszczy, J $u The Institute of Cancer Research, London, UK.
700    1_
$a Mettling, C $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Domiciliation, Activation Immunitaire et Infection, Montpellier, France.
700    1_
$a Dardillac, E $u Université Paris Sud, CNRS, UMR 8200 and Institut de Cancérologie Gustave Roussy, Ligue Contre le Cancer, Villejuif, France.
700    1_
$a Barthe, A $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
700    1_
$a Schmitz, A L $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
700    1_
$a Promonet, A $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
700    1_
$a Cribier, A $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire de Virologie Moléculaire, Montpellier, France.
700    1_
$a Sarrazin, A $u BioCampus Montpellier, Université de Montpellier, CNRS, Montpellier, France.
700    1_
$a Niedzwiedz, W $u The Institute of Cancer Research, London, UK.
700    1_
$a Lopez, B $u Université Paris Sud, CNRS, UMR 8200 and Institut de Cancérologie Gustave Roussy, Ligue Contre le Cancer, Villejuif, France.
700    1_
$a Costanzo, V $u IFOM, The FIRC Institute of Molecular Oncology, Milan, Italy.
700    1_
$a Krejci, L $u Department of Medical Biochemistry and Biophysics and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden. International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic.
700    1_
$a Chabes, A $u Department of Medical Biochemistry and Biophysics and Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå University, Umeå, Sweden.
700    1_
$a Benkirane, M $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire de Virologie Moléculaire, Montpellier, France.
700    1_
$a Lin, Y L $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
700    1_
$a Pasero, P $u Institut de Génétique Humaine, CNRS, Université de Montpellier, Laboratoire Maintien de l'Intégrité du Génome au cours de la Réplication, Ligue Contre le Cancer, Montpellier, France.
773    0_
$w MED00006670 $t Comptes rendus biologies $x 1768-3238 $g Roč. 343, č. 1 (2020), s. 9-21
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32720483 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114153001 $b ABA008
999    __
$a ok $b bmc $g 1608438 $s 1119283
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 343 $c 1 $d 9-21 $e 20200605 $i 1768-3238 $m Comptes rendus. Biologies $n C. r., Biol. $x MED00006670
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Možnosti archivace